NEWSALY™
    A World Of News, One Window.Saturday, October 24, 2026
    world

    Una vacuna experimental contra el melanoma reduce un 42% el riesgo de recaída o muerte y abre la puerta a tratamientos personalizados

    20minutos
    October 24, 2026
    via 20minutos

    You're reading one story from Newsaly

    Newsaly brings together 60,000+ newspaper articles, 30,000+ podcasts and 10,000+ magazine articles from around the world.

    A World Of News, One Window.

    Explore Today's News
    Una vacuna experimental contra el melanoma reduce un 42% el riesgo de recaída o muerte y abre la puerta a tratamientos personalizados

    El tratamiento experimental combina una vacuna personalizada con inmunoterapia y ha mostrado resultados prometedores en un ensayo con 1.137 pacientes, aunque todavía requiere más seguimiento.

    Read the full story

    Explore More On Newsaly

    60,000+ Newspaper Articles

    Explore newspapers from around the world.

    Explore Newspapers

    30,000+ Podcasts

    Discover podcasts and listen to the latest conversations and news.

    Explore Podcasts

    10,000+ Magazine Articles

    Explore magazine articles from around the world.

    Explore Magazines

    Voices (0)

    Share a 15-second voice reaction. Voices automatically disappear after 10 days.

    Sign in to record a voice on this article.

    Be the first to share a voice on this article.